This Senate resolution officially designates May 2026 as "ALS Awareness Month" to significantly increase public understanding and recognition of Amyotrophic Lateral Sclerosis. It highlights ALS as a devastating, progressive neurodegenerative disease that affects nerve cells, leading to muscle weakness, paralysis, and ultimately, respiratory failure, with a life expectancy of only 2 to 5 years post-diagnosis. The resolution underscores that ALS affects thousands of individuals annually across all demographics, with military veterans being particularly susceptible, and currently has no cure. It notes the significant financial and emotional burdens faced by patients and their caregivers due to the high costs of medical care, equipment, and home services as the disease progresses. Furthermore, the Senate affirms its dedication to ensuring individuals with ALS receive early access to effective treatments and high-quality services , while also working to identify risk factors and causes to prevent new cases. The resolution also aims to empower patients to maintain personal independence and reduce the physical and emotional challenges associated with the disease. Finally, the resolution commends the tireless efforts of family members, friends, organizations, volunteers, researchers, and caregivers nationwide. These dedicated individuals are working to improve the quality and length of life for ALS patients and accelerate the development of much-needed treatments and cures.